School of Medicine
Showing 51-100 of 284 Results
-
Atman Desai, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsThe Stanford Spine Artificial Intelligence Laboratory, led by Dr. Atman Desai MD, MA, FACS, is a collaboration of Stanford neurosurgeons, radiologists, orthopedic surgeons and data scientists who share the goal of advancing the field of artificial intelligence to provide better surgical outcomes for spine patients. Our laboratory works closely with the Stanford Center for Artificial Intelligence in Medicine and Imaging, and studies the application of computer vision and deep learning to spinal i
-
Jun Ding
Associate Professor of Neurosurgery and of Neurology
On Leave from 02/01/2024 To 07/31/2024Current Research and Scholarly InterestsNeural circuits of movement control in health and movement disorders
-
Robert Dodd, MD, PhD
Associate Professor of Neurosurgery, of Radiology and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
Current Research and Scholarly InterestsDr. Dodd is involved in clinical trials using endovascular coils that have a fiber coating that help heal aneurysms of the neck and can prevent an aneurysm from reforming. He uses minimally invasive endoscopic techniques to treat brain tumors.
Dodd's research interests are in cerebral blood vessel reactivity and stroke. -
Amirreza Ehsani, MD
Visiting Instructor, Neurosurgery
BioAmirreza Ehsani is an MD and completed his undergraduate education at Iran University of Medical Sciences(IUMS), Tehran, Iran. After his graduation, he continued research in surgical fields and also practicing medicine in private clinics in Tehran, Iran.
Dr. Ehsani joined the Stanford Neurosurgery department in November, 2022, as a Visiting Instructor. His research focuses on clinical neurosurgery and immunotherapy for many benign and malignant brain pathologies. -
Ryann Fame
Assistant Professor of Neurosurgery
Current Research and Scholarly InterestsEarly neural progenitors respond to extrinsic cues that maintain and support their potency. These stem/ progenitor cells are in direct contact with the cerebrospinal fluid (CSF), which acts as part of their niche. Our research program encompasses the early neural stem cell niche, neural tube closure, CSF, metabolism, and cortical neuronal development. We are dedicated to broad collaboration focused on translating an understanding of neurodevelopment and CSF biology into regenerative strategies.
-
Juan Carlos Fernandez-Miranda
Professor of Neurosurgery and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS)
BioDr. Juan Fernandez-Miranda is Professor of Neurosurgery and Surgical Director of the Stanford Brain Tumor, Skull Base, and Pituitary Centers. He is internationally renowned for his expertise in minimally invasive brain surgery, endoscopic skull base and pituitary surgery, open skull base surgery, and complex brain tumor surgery. He has performed nearly 3,000 cranial operations including over 1,500 endoscopic endonasal operations for pituitary tumors and other skull base lesions. He is highly regarded for his innovative contributions to the development and refinement of endoscopic endonasal skull base surgery, for his ability to select the most effective and less invasive approach to each individual patient, and for his precise knowledge of the intricate anatomy of the white matter tracts required to maximize resection and minimize morbidity on high and low grade glioma patients. He has been recently ranked by Expertscape as World-Expert (top 0.05%) on Skull Base Surgery and #1 Neurosurgeon Expert on Skull Base Tumors (pituitary adenomas, meningiomas, craniopharyngiomas, chordomas, chondrosarcomas, schwannomas and esthesioneuroblastomas) on the US Pacific Region. He is co-founder and vice-president of the International Rhoton Society and executive member of the Board of Directors of the The Neurosurgical Atlas, the largest nonprofit organization for neurosurgical education and research in the world.
Dr. Fernandez-Miranda completed neurosurgery residency at La Paz University Hospital in Madrid, Spain. Upon completion of his residency, he was awarded the Sanitas Prize to the best medical postgraduate trainee in the country. From 2005 to 2007, he underwent fellowship training in microsurgical neuroanatomy at the University of Florida under legendary neurosurgeon Albert L. Rhoton, Jr. From 2007 to 2010 he continued subspecialty clinical training in cerebrovascular surgery at the University of Virginia, and endoscopic endonasal and open skull base surgery at University of Pittsburgh Medical Center (UPMC). During his 10-year tenure at UPMC, he pioneered endoscopic endonasal approaches to highly complex pituitary and skull base tumors, developed a world-class complex brain surgery program, and led a premier training and research program on surgical neuroanatomy and skull base surgery.
In 2018, he was recruited to bring to Stanford his unique technical expertise and to collaborate with world-renowned Stanford colleagues across multiple disciplines, leading the establishment of one of the most preeminent centers worldwide for comprehensive treatment of complex lesions in the brain, skull base, and pituitary regions. His top priority is to provide gentle, accurate, and safe surgery, in a team-based and compassionate approach to patient care. -
Paul Graham Fisher, MD
Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Current Research and Scholarly InterestsClinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.
-
Robert Fisher, MD, PhD
The Maslah Saul, MD, Professor and Professor, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.
-
Paul George, MD, PhD
Assistant Professor of Neurology (Adult Neurology) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsCONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.
BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.
APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes. -
Iris C. Gibbs, MD, FACR, FASTRO
Professor of Radiation Oncology (Radiation Therapy) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsDr. Gibbs is a board-certified radiation oncologist who specializes in the treatment of CNS tumors. Her research focuses on developing new radiation techniques to manage brain and spinal tumors in adults and children. Dr. Gibbs has gained worldwide acclaim for her expertise in Cyberknife robotic radiosurgery.
-
Carl Gold
Clinical Associate Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryBioDr. Gold is a board-certified neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold's primary research interest focuses on enhancing the communication skills of neurology residents, and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.
Dr. Gold serves as Vice Chair of Quality, Safety, & Experience for the Department of Neurology & Neurological Sciences. In this role, he coordinates projects aimed at improving care for patients with neurological conditions across the health system.
For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html
Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html
Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html -
Seunggu Jude Han, MD
Clinical Associate Professor, Neurosurgery
BioDr. Han is a board-certified neurosurgeon with fellowship training in neuro-oncology. He is also a clinical associate professor in the Department of Neurosurgery at Stanford University School of Medicine and chief of neurosurgery at Palo Alto VA Medical Center.
Dr. Han diagnoses and treats a wide range of conditions, including brain tumors, pituitary tumors, spinal tumors, and degenerative spinal disorders. He is passionate about caring for underserved populations, as well as educating and mentoring the next generation of neurosurgeons.
Dr. Han’s academic and research interests include brain mapping, advancing diagnostic methods and treatments for brain tumors, and improving the quality of neurosurgical care. He has conducted several clinical trials to determine the safety and effectiveness of specific treatments for different tumors affecting the central nervous system.
Dr. Han has published over 100 peer-reviewed articles in prestigious journals, including Neurology, Neurosurgery, Neuro-Oncology, and the Journal of Neurosurgery. He also serves as a reviewer for many professional publications.
Dr. Han is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, and the Society for Neuro-Oncology. He serves as an executive committee member and abstract reviewer for annual conferences in several of these organizations. -
Summer Han
Associate Professor (Research) of Neurosurgery, of Medicine (Biomedical Informatics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsMy current research focuses on understanding the genetic and environmental etiology of complex disease and developing and evaluating efficient screening strategies based on etiological understanding. The areas of my research interests include statistical genetics, molecular epidemiology, cancer screening, health policy modeling, and risk prediction modeling. I have developed various statistical methods to analyze high-dimensional data to identify genetic and environmental risk factors and their interactions for complex disease.
-
Ciara Harraher, MD
Clinical Professor, Neurosurgery
Current Research and Scholarly InterestsI am interested in medical education and I am an Associate in the Practice of Medicine and doctoring with CARE ( E4C) Program. I am also interested in surgical outcomes research and I am involved in clinical trials studying brain tumors and stroke. I have also presented internationally on issues related to improving diversity in Neurosurgery.
-
Odette Harris, MD, MPH
Paralyzed Veterans of America Professor of Spinal Cord Injury Medicine
Current Research and Scholarly InterestsTraumatic brain injury with a focus on epidemiology and outcomes.
-
Melanie Hayden Gephart
Professor of Neurosurgery and, by courtesy, of Neurology
BioI am a brain tumor neurosurgeon, treating patients with primary and metastatic brain tumors. I treat patients with malignant and benign tumors, including glioma, brain metastases, meningioma, and vestibular schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cell free nucleic acid biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.
www.GephartLab.com
www.GBMseq.org
https://stan.md/BrainMets
@HaydenGephartMD -
Jeremy J. Heit, MD, PhD
Associate Professor of Radiology (Neuroimaging and Neurointervention) and, by courtesy, of Neurosurgery
Current Research and Scholarly InterestsOur research seeks to advance our understanding of cerebrovascular disease and to develop new minimally invasive treatments for these diseases. We study ischemic and hemorrhagic stroke, cerebral aneurysms, delayed cerebral ischemia, cerebral arteriovenous malformations (AVMs), dural arteriovenous fistulae, and other vascular diseases of the brain. We use state-of-the-art neuroimaging techniques to non-invasively study these diseases, and we are developing future endovascular technologies to advance neurointerventional surgery.
www.heitlab.com -
Jaimie Henderson, MD
John and Jene Blume - Robert and Ruth Halperin Professor, Professor of Neurosurgery and, by courtesy, of Neurology
Current Research and Scholarly InterestsMy research interests encompass several areas of stereotactic and functional neurosurgery, including frameless stereotactic approaches for therapy delivery to deep brain nuclei; cortical physiology and its relationship to normal and pathological movement; brain-computer interfaces; and the development of novel neuromodulatory techniques for the treatment of movement disorders, epilepsy, pain, and other neurological diseases.
-
Yusuke Hori, MD
Clinical Instructor, Neurosurgery
BioDr. Hori received his MD from Sapporo Medical University, Japan, and during that time he served as a Medical Student Research Fellow in the Department of Pharmacology. He explored the functional role of the SIRT1 gene, a longevity-associated gene, and its association with various conditions such as muscular dystrophy. He also completed a Visiting Student Research Fellowship at the Health Sciences University of Hokkaido and participated in Human Genetics projects focusing on an association between the 27-bp deletion and 538G>A mutation in the ABCC11 Gene.
After graduating from medical school, Dr. Hori completed a neurosurgery residency at National Hospital Organization Okayama Medical Center in Japan. Subsequently, he completed a Stereotactic and Functional Neurosurgery Fellowship and then a Neurosurgical Oncology and Radiosurgery Fellowship at The Cleveland Clinic. He also completed an International Neurosurgery Fellowship at Boston Children's Hospital, Harvard Medical School. In 2022, he moved to Stanford University as a postdoctoral fellow, and under the supervision of Dr. Anca Pasca, he participated in brain organoid research focusing on hypoxic brain injuries.
Since July 2023, Dr. Hori has been working as a Clinical Instructor (Neurosurgical Oncology and Radiosurgery) in the Department of Neurosurgery at Stanford under the supervision of Dr. Steven D. Chang. His clinical interests include malignant brain and spine tumors in both adult and pediatric patients. His clinical research focuses on the application of minimally invasive treatments such as laser interstitial thermal therapy, focused ultrasound, and radiosurgery to treat various neurosurgical conditions. His current lab research aims to develop an organoid model for radiation-induced brain injuries and a high-throughput screening platform to identify novel therapeutic compounds, for which he received a Clinician Educator Grant from Stanford University Maternal and Child Health Research Institute. Outside of medicine, he enjoys playing music including guitar and drums. -
Serena Hu, MD
Professor of Orthopaedic Surgery and, by courtesy, of Neurosurgery
BioDr. Hu is a board-certified, fellowship-trained orthopaedic spine surgeon. She is professor and vice chair of the Department of Orthopaedic Surgery and (by courtesy) Neurosurgery, and chief of the Division of Spine Surgery at Stanford University School of Medicine. Dr. Hu completed her orthopedic surgery residency at the Hospital for Special Surgery in New York and her fellowship training in spine and scoliosis surgery at Rancho Los Amigos Rehabilitation Center in Downey, California.
Dr. Hu has extensive experience helping patients with a range of spinal conditions and injuries. She specializes in treating scoliosis (when the spine curves sideways), kyphosis (when the spine is more bent forward than normal) lumbar spine fractures, spondylolisthesis (when a vertebra moves out of place), disc degeneration, and spinal stenosis (spinal canal narrowing). Dr. Hu draws on her expertise to create a customized care plan for each of her patients.
Dr. Hu has been the principal investigator in more than a dozen clinical trials and studies. She has been awarded multiple research grants from the North American Spine Society, Scoliosis Research Society, and the National Institutes of Health (NIH). Her research interests include the effects of preoperative pain medication on surgical outcomes as well as decreasing the risk of complications after spine surgery. She has also studied and tested new technologies that make spine surgery safer and more effective.
She has published more than 145 articles in dozens of peer-reviewed journals, including Global Spine Journal, Journal of Spine Surgery, Spine, and Spine Deformity. She has written about a range of topics, including quality measures in spine surgery, spinal fusion techniques, spine tumor effects on spine stability and lumbar decompression for spinal stenosis. Additionally, Dr. Hu has written more than a dozen book chapters on spinal cord injuries, spine fractures, pediatric kyphosis, spondylolysis (vertebra fracture), and scoliosis.
Dr. Hu has reviewed articles for Clinical Orthopaedics and Related Research, Journal of the American Academy of Orthopaedic Surgeons: A Comprehensive Review, and Spine. She has also served as associate editor for Spine Deformity and deputy editor for Global Spine Journal.
Having delivered hundreds of presentations, papers, and lectures, Dr. Hu is widely considered one of the world’s leading experts in spine surgery. She has been invited to lecture to her colleagues all over the United States and around the world, including in Hong Kong, Canada, Brazil, Australia, Argentina, and Greece.
Dr. Hu is a member of multiple professional organizations, including the American Academy of Orthopaedic Surgeons, American Orthopaedic Association, International Society for the Study of the Lumbar Spine, Orthopaedic Research Society, and Scoliosis Research Society. She is past president of the Scoliosis Research Society as well as of the American Orthopedic Association. -
Yuhao (Danny) Huang
Affiliate, Dean's Office Operations - Dean Other
Resident in NeurosurgeryBioI am a resident and post-doctorate researcher in the Department of Neurosurgery at Stanford University. As a physician-scientist with a focus on signal processing and neural electrophysiology, I work with multimodal datasets to understand how brain signals correlate with human behavior. I am interested in using computer vision and machine learning to parse neural correlates of behavior under naturalistic settings. Another area of interest involves building robust neuro-modulatory treatments for functional disorders and epilepsy. I received my BSc at University of Alberta and my MD at Stanford University.
